Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 227 entries
Sorted by: Best Match Show Resources per page
A biotic game design project for integrated life science and engineering education

engineering education

Cira NJ, Chung AM, Denisin AK, Rensi S.
GSID: IcPrylt0CWYJ
NJ Cira, AM Chung, AK Denisin, S Rensi… - PLoS …, 2015 - journals.plos.org

Engaging, hands-on design experiences are key for formal and informal Science, Technology, Engineering, and Mathematics (STEM) education. Robotic and video game design challenges have been particularly effective in stimulating student interest, but equivalent …

Cite
Cira, N. J., Chung, A. M., Denisin, A. K., Rensi, S., Sanchez, G. N., Quake, S. R., & Riedel-Kruse, I. H. (2015). A biotic game design project for integrated life science and engineering education. PLoS biology, 13(3), e1002110.
Cira, Nate J., et al. "A biotic game design project for integrated life science and engineering education." PLoS biology 13.3 (2015): e1002110.
Copy Download .nbib Format: MLA
Characterization of resting state activity in MCI individuals.

PeerJ

Esposito R, Mosca A, Pieramico V, Cieri F, Cera N, Sensi SL.
PMID: 24010015
PeerJ. 2013 Aug 20;1:e135. doi: 10.7717/peerj.135. eCollection 2013.

Objectives. Aging is the major risk factor for Alzheimer Disease (AD) and Mild Cognitive Impairment (MCI). The aim of this study was to identify novel modifications of brain functional connectivity in MCI patients. MCI individuals were compared to healthy...

Cite
Esposito R, Mosca A, Pieramico V, et al. Characterization of resting state activity in MCI individuals. PeerJ. 2013;1:e135doi: 10.7717/peerj.135.
Esposito, R., Mosca, A., Pieramico, V., Cieri, F., Cera, N., & Sensi, S. L. (2013). Characterization of resting state activity in MCI individuals. PeerJ, 1e135. https://doi.org/10.7717/peerj.135
Esposito, Roberto, et al. "Characterization of resting state activity in MCI individuals." PeerJ vol. 1 (2013): e135. doi: https://doi.org/10.7717/peerj.135
Esposito R, Mosca A, Pieramico V, Cieri F, Cera N, Sensi SL. Characterization of resting state activity in MCI individuals. PeerJ. 2013 Aug 20;1:e135. doi: 10.7717/peerj.135. eCollection 2013. PMID: 24010015; PMCID: PMC3757508.
Copy Download .nbib Format: NLM
Reactivity of the Excited States of the H-Cluster of FeFe Hydrogenases.

Journal of the American Chemical Society

Sensi M, Baffert C, Greco C, Caserta G, Gauquelin C, Saujet L, Fontecave M, Roy S, Artero V, Soucaille P, Meynial-Salles I, Bottin H, de Gioia L, Fourmond V, Léger C, Bertini L.
PMID: 27649394
J Am Chem Soc. 2016 Oct 19;138(41):13612-13618. doi: 10.1021/jacs.6b06603. Epub 2016 Oct 06.

FeFe hydrogenases catalyze H

Cite
Sensi M, Baffert C, Greco C, et al. Reactivity of the Excited States of the H-Cluster of FeFe Hydrogenases. J Am Chem Soc. 2016;138(41):13612-13618doi: 10.1021/jacs.6b06603.
Sensi, M., Baffert, C., Greco, C., Caserta, G., Gauquelin, C., Saujet, L., Fontecave, M., Roy, S., Artero, V., Soucaille, P., Meynial-Salles, I., Bottin, H., de Gioia, L., Fourmond, V., Léger, C., & Bertini, L. (2016). Reactivity of the Excited States of the H-Cluster of FeFe Hydrogenases. Journal of the American Chemical Society, 138(41), 13612-13618. https://doi.org/10.1021/jacs.6b06603
Sensi, Matteo, et al. "Reactivity of the Excited States of the H-Cluster of FeFe Hydrogenases." Journal of the American Chemical Society vol. 138,41 (2016): 13612-13618. doi: https://doi.org/10.1021/jacs.6b06603
Sensi M, Baffert C, Greco C, Caserta G, Gauquelin C, Saujet L, Fontecave M, Roy S, Artero V, Soucaille P, Meynial-Salles I, Bottin H, de Gioia L, Fourmond V, Léger C, Bertini L. Reactivity of the Excited States of the H-Cluster of FeFe Hydrogenases. J Am Chem Soc. 2016 Oct 19;138(41):13612-13618. doi: 10.1021/jacs.6b06603. Epub 2016 Oct 06. PMID: 27649394.
Copy Download .nbib Format: NLM
MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers.

Frontiers in immunology

Monaci E, Mancini F, Lofano G, Bacconi M, Tavarini S, Sammicheli C, Arcidiacono L, Giraldi M, Galletti B, Rossi Paccani S, Torre A, Fontana MR, Grandi G, de Gregorio E, Bensi G, Chiarot E, Nuti S, Bagnoli F, Soldaini E, Bertholet S.
PMID: 26441955
Front Immunol. 2015 Sep 07;6:439. doi: 10.3389/fimmu.2015.00439. eCollection 2015.

Staphylococcus aureus (S. aureus) is an important opportunistic pathogen that may cause invasive life-threatening infections, like sepsis and pneumonia. Due to the increasing antibiotic resistance, the development of an effective vaccine against S. aureus is needed. Although a correlate...

Cite
Monaci E, Mancini F, Lofano G, et al. MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers. Front Immunol. 2015;6:439doi: 10.3389/fimmu.2015.00439.
Monaci, E., Mancini, F., Lofano, G., Bacconi, M., Tavarini, S., Sammicheli, C., Arcidiacono, L., Giraldi, M., Galletti, B., Rossi Paccani, S., Torre, A., Fontana, M. R., Grandi, G., de Gregorio, E., Bensi, G., Chiarot, E., Nuti, S., Bagnoli, F., Soldaini, E., & Bertholet, S. (2015). MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers. Frontiers in immunology, 6439. https://doi.org/10.3389/fimmu.2015.00439
Monaci, Elisabetta, et al. "MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers." Frontiers in immunology vol. 6 (2015): 439. doi: https://doi.org/10.3389/fimmu.2015.00439
Monaci E, Mancini F, Lofano G, Bacconi M, Tavarini S, Sammicheli C, Arcidiacono L, Giraldi M, Galletti B, Rossi Paccani S, Torre A, Fontana MR, Grandi G, de Gregorio E, Bensi G, Chiarot E, Nuti S, Bagnoli F, Soldaini E, Bertholet S. MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers. Front Immunol. 2015 Sep 07;6:439. doi: 10.3389/fimmu.2015.00439. eCollection 2015. PMID: 26441955; PMCID: PMC4561515.
Copy Download .nbib Format: NLM
Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics.

World journal of virology

Asensi V, Collazos J, Valle-Garay E.
PMID: 26279978
World J Virol. 2015 Aug 12;4(3):169-77. doi: 10.5501/wjv.v4.i3.169.

Pharmacogenetics refers to the effect of single nucleotide polymorphisms (SNPs) within human genes on drug therapy outcome. Its study might help clinicians to increase the efficacy of antiretroviral drugs by improving their pharmacokinetics and pharmacodynamics and by decreasing their...

Cite
Asensi V, Collazos J, Valle-Garay E. Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics. World J Virol. 2015;4(3):169-77doi: 10.5501/wjv.v4.i3.169.
Asensi, V., Collazos, J., & Valle-Garay, E. (2015). Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics. World journal of virology, 4(3), 169-77. https://doi.org/10.5501/wjv.v4.i3.169
Asensi, Victor, et al. "Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics." World journal of virology vol. 4,3 (2015): 169-77. doi: https://doi.org/10.5501/wjv.v4.i3.169
Asensi V, Collazos J, Valle-Garay E. Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics. World J Virol. 2015 Aug 12;4(3):169-77. doi: 10.5501/wjv.v4.i3.169. PMID: 26279978; PMCID: PMC4534808.
Copy Download .nbib Format: NLM
Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X).

Case reports in pediatrics

Cappella M, Graziani V, Pragliola A, Sensi A, Hussain K, Muratori C, Marchetti F.
PMID: 26064751
Case Rep Pediatr. 2015;2015:561974. doi: 10.1155/2015/561974. Epub 2015 Apr 29.

Hyperinsulinemic hypoglycaemia (HH) is a group of clinically, genetically, and morphologically heterogeneous disorders characterized by dysregulation of insulin secretion by pancreatic beta cells. HH can either be congenital genetic hyperinsulinism or associated with metabolic disorder and syndromic condition. Early...

Cite
Cappella M, Graziani V, Pragliola A, et al. Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X). Case Rep Pediatr. 2015;2015:561974doi: 10.1155/2015/561974.
Cappella, M., Graziani, V., Pragliola, A., Sensi, A., Hussain, K., Muratori, C., & Marchetti, F. (2015). Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X). Case reports in pediatrics, 2015561974. https://doi.org/10.1155/2015/561974
Cappella, Michela, et al. "Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X)." Case reports in pediatrics vol. 2015 (2015): 561974. doi: https://doi.org/10.1155/2015/561974
Cappella M, Graziani V, Pragliola A, Sensi A, Hussain K, Muratori C, Marchetti F. Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X). Case Rep Pediatr. 2015;2015:561974. doi: 10.1155/2015/561974. Epub 2015 Apr 29. PMID: 26064751; PMCID: PMC4429216.
Copy Download .nbib Format: NLM
Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma.

International journal of immunopathology and pharmacology

Riccioni G, Castronuovo M, De Benedictis M, Pace - Palitti V, Di Gioacchino M, Della Vecchia R, Schiavone C, Sensi S, Guagnano MT.
PMID: 12604023
Int J Immunopathol Pharmacol. 2001 May-Aug;14(2):87-92.

Asthma is one of the most common chronic diseases in children and adults. Recent studies have shown that in asthmatic patients treated with inhaled corticosteroids there is a better disease’s control when adding a second drug, than increasing the...

Cite
Riccioni G, Castronuovo M, De Benedictis M, et al. Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma. Int J Immunopathol Pharmacol. 2001;14(2):87-92
Riccioni, G., Castronuovo, M., De Benedictis, M., Pace - Palitti, V., Di Gioacchino, M., Della Vecchia, R., Schiavone, C., Sensi, S., & Guagnano, M. T. (2001). Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma. International journal of immunopathology and pharmacology, 14(2), 87-92.
Riccioni, G, et al. "Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma." International journal of immunopathology and pharmacology vol. 14,2 (2001): 87-92.
Riccioni G, Castronuovo M, De Benedictis M, Pace - Palitti V, Di Gioacchino M, Della Vecchia R, Schiavone C, Sensi S, Guagnano MT. Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma. Int J Immunopathol Pharmacol. 2001 May-Aug;14(2):87-92. PMID: 12604023.
Copy Download .nbib Format: NLM
Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma.

International journal of immunopathology and pharmacology

Riccioni G, Ballone E, D'Orazio N, Sensi S, Di Nicola M, Di Mascio R, Santilli F, Guagnano MT, Della Vecchia R.
PMID: 12590877
Int J Immunopathol Pharmacol. 2002 May-Aug;15(2):149-155. doi: 10.1177/039463200201500210.

Insufficient data exist to evaluate the comparative effects of inhaled corticosteroids (ICS) versus leukotriene receptor antagonist (LTRA) on airway inflammation and quality of life (QoL). The aim of the study was to compare the effectiveness of montelukast compared to...

Cite
Riccioni G, Ballone E, D'Orazio N, et al. Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma. Int J Immunopathol Pharmacol. 2002;15(2):149-155doi: 10.1177/039463200201500210.
Riccioni, G., Ballone, E., D'Orazio, N., Sensi, S., Di Nicola, M., Di Mascio, R., Santilli, F., Guagnano, M. T., & Della Vecchia, R. (2002). Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma. International journal of immunopathology and pharmacology, 15(2), 149-155. https://doi.org/10.1177/039463200201500210
Riccioni, G., et al. "Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma." International journal of immunopathology and pharmacology vol. 15,2 (2002): 149-155. doi: https://doi.org/10.1177/039463200201500210
Riccioni G, Ballone E, D'Orazio N, Sensi S, Di Nicola M, Di Mascio R, Santilli F, Guagnano MT, Della Vecchia R. Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma. Int J Immunopathol Pharmacol. 2002 May-Aug;15(2):149-155. doi: 10.1177/039463200201500210. PMID: 12590877.
Copy Download .nbib Format: NLM
Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies.

The Neurohospitalist

Marrodan M, Bensi C, Alessandro L, Muggeri AD, Farez MF.
PMID: 30245767
Neurohospitalist. 2018 Oct;8(4):177-182. doi: 10.1177/1941874418773924. Epub 2018 May 06.

BACKGROUND AND PURPOSE: Although incidence rates vary, infectious, autoimmune, and neoplastic diseases can all cause chronic and subacute meningitis (CSM). We report a Latin-American, single center, CSM case series, analyzing the main clinical characteristics as well as ancillary diagnostic...

Cite
Marrodan M, Bensi C, Alessandro L, et al. Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies. Neurohospitalist. 2018;8(4):177-182doi: 10.1177/1941874418773924.
Marrodan, M., Bensi, C., Alessandro, L., Muggeri, A. D., & Farez, M. F. (2018). Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies. The Neurohospitalist, 8(4), 177-182. https://doi.org/10.1177/1941874418773924
Marrodan, Mariano, et al. "Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies." The Neurohospitalist vol. 8,4 (2018): 177-182. doi: https://doi.org/10.1177/1941874418773924
Marrodan M, Bensi C, Alessandro L, Muggeri AD, Farez MF. Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies. Neurohospitalist. 2018 Oct;8(4):177-182. doi: 10.1177/1941874418773924. Epub 2018 May 06. PMID: 30245767; PMCID: PMC6146350.
Copy Download .nbib Format: NLM
Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis.

Oncotarget

Hu G, Niu F, Humburg BA, Liao K, Bendi S, Callen S, Fox HS, Buch S.
PMID: 29719633
Oncotarget. 2018 Jan 01;9(26):18648-18663. doi: 10.18632/oncotarget.24307. eCollection 2018 Apr 06.

LncRNAs are long non-coding regulatory RNAs that are longer than 200 nucleotides. One of the major functions of lncRNAs is the regulation of specific gene expression at multiple steps including, recruitment and expression of basal transcription machinery, post-transcriptional modifications...

Cite
Hu G, Niu F, Humburg BA, et al. Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis. Oncotarget. 2018;9(26):18648-18663doi: 10.18632/oncotarget.24307.
Hu, G., Niu, F., Humburg, B. A., Liao, K., Bendi, S., Callen, S., Fox, H. S., & Buch, S. (2018). Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis. Oncotarget, 9(26), 18648-18663. https://doi.org/10.18632/oncotarget.24307
Hu, Guoku, et al. "Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis." Oncotarget vol. 9,26 (2018): 18648-18663. doi: https://doi.org/10.18632/oncotarget.24307
Hu G, Niu F, Humburg BA, Liao K, Bendi S, Callen S, Fox HS, Buch S. Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis. Oncotarget. 2018 Jan 01;9(26):18648-18663. doi: 10.18632/oncotarget.24307. eCollection 2018 Apr 06. PMID: 29719633; PMCID: PMC5915100.
Copy Download .nbib Format: NLM
Structural Effects on the Spin Dynamics of Potential Molecular Qubits.

Inorganic chemistry

Atzori M, Benci S, Morra E, Tesi L, Chiesa M, Torre R, Sorace L, Sessoli R.
PMID: 29280628
Inorg Chem. 2018 Jan 16;57(2):731-740. doi: 10.1021/acs.inorgchem.7b02616. Epub 2017 Dec 27.

Control of spin-lattice magnetic relaxation is crucial to observe long quantum coherence in spin systems at reasonable temperatures. Such a control is most often extremely difficult to achieve, because of the coexistence of several relaxation mechanisms, that is direct,...

Cite
Atzori M, Benci S, Morra E, et al. Structural Effects on the Spin Dynamics of Potential Molecular Qubits. Inorg Chem. 2017;57(2):731-740doi: 10.1021/acs.inorgchem.7b02616.
Atzori, M., Benci, S., Morra, E., Tesi, L., Chiesa, M., Torre, R., Sorace, L., & Sessoli, R. (2018). Structural Effects on the Spin Dynamics of Potential Molecular Qubits. Inorganic chemistry, 57(2), 731-740. https://doi.org/10.1021/acs.inorgchem.7b02616
Atzori, Matteo, et al. "Structural Effects on the Spin Dynamics of Potential Molecular Qubits." Inorganic chemistry vol. 57,2 (2018): 731-740. doi: https://doi.org/10.1021/acs.inorgchem.7b02616
Atzori M, Benci S, Morra E, Tesi L, Chiesa M, Torre R, Sorace L, Sessoli R. Structural Effects on the Spin Dynamics of Potential Molecular Qubits. Inorg Chem. 2018 Jan 16;57(2):731-740. doi: 10.1021/acs.inorgchem.7b02616. Epub 2017 Dec 27. PMID: 29280628.
Copy Download .nbib Format: NLM
Cost and effectiveness of lung lobectomy by video-assisted thoracic surgery for lung cancer.

Journal of thoracic disease

Mafé JJ, Planelles B, Asensio S, Cerezal J, Inda MD, Lacueva J, Esteban MD, Hernández L, Martín C, Baschwitz B, Peiró AM.
PMID: 28932560
J Thorac Dis. 2017 Aug;9(8):2534-2543. doi: 10.21037/jtd.2017.07.51.

BACKGROUND: Video-assisted thoracic surgery (VATS) emerged as a minimally invasive surgery for diseases in the field of thoracic surgery. We herein reviewed our experience on thoracoscopic lobectomy for early lung cancer and evaluated Health System use.METHODS: A cost-effectiveness study...

Cite
Mafé JJ, Planelles B, Asensio S, et al. Cost and effectiveness of lung lobectomy by video-assisted thoracic surgery for lung cancer. J Thorac Dis. 2017;9(8):2534-2543doi: 10.21037/jtd.2017.07.51.
Mafé, J. J., Planelles, B., Asensio, S., Cerezal, J., Inda, M. D., Lacueva, J., Esteban, M. D., Hernández, L., Martín, C., Baschwitz, B., & Peiró, A. M. (2017). Cost and effectiveness of lung lobectomy by video-assisted thoracic surgery for lung cancer. Journal of thoracic disease, 9(8), 2534-2543. https://doi.org/10.21037/jtd.2017.07.51
Mafé, Juan J, et al. "Cost and effectiveness of lung lobectomy by video-assisted thoracic surgery for lung cancer." Journal of thoracic disease vol. 9,8 (2017): 2534-2543. doi: https://doi.org/10.21037/jtd.2017.07.51
Mafé JJ, Planelles B, Asensio S, Cerezal J, Inda MD, Lacueva J, Esteban MD, Hernández L, Martín C, Baschwitz B, Peiró AM. Cost and effectiveness of lung lobectomy by video-assisted thoracic surgery for lung cancer. J Thorac Dis. 2017 Aug;9(8):2534-2543. doi: 10.21037/jtd.2017.07.51. PMID: 28932560; PMCID: PMC5594203.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 227 entries